Cynvenio Links With Cure Forward

Westlake Village-based Cynvenio Biosystems said Thursday that it has linked with Cure Forward, a provider of web-based paltforms for patients to share genetic testing results, to help cancer patients with their treatments. According to the two, the deal will help patients and physiciansleverage results from Cynvenio's ClearID genomic test, which uses whole blood draw to profile cancer tumor cells. Financial details of the partnership were not announced. Cynvenio says its blood testing is currently used to assess breast, prostate and colorectal cancers. The company raised $25.5M in a venture funding round earlier this week.